Vitamin DNEW2026-08

Vitamin D₃ in cancer prevention and therapy: molecular mechanisms, clinical evidence, and future perspectives.

Khan Shahid Ullah, Saeed Sumbul, Sheikh Hajer N, Ali Akbar et al. — Molecular biology reports

Summary

This paper reviews the current scientific understanding of how Vitamin D3 might help prevent and treat cancer. It explores the ways Vitamin D affects cancer cells and summarizes existing clinical studies on its use alongside standard cancer treatments. While promising, more research is needed to confirm its benefits and determine the best way to use it.

AI-generated summary — read the original

Key points

Vitamin D3 plays a role in regulating cell growth and death, which are important processes in cancer development.
Some studies suggest that Vitamin D3 supplementation may offer benefits when used with conventional cancer treatments.
The effectiveness of Vitamin D3 in cancer treatment can vary depending on the type of cancer and individual patient factors.
Further large-scale studies are essential to confirm Vitamin D3's role and establish clear guidelines for its use in cancer care.

What the study looked at

This review paper investigated the current scientific understanding of how Vitamin D3 might influence cancer, both in preventing its development and supporting its treatment. It aimed to consolidate knowledge on the molecular mechanisms involved and evaluate existing clinical evidence. Researchers conducted a comprehensive review of published scientific literature, analyzing studies that explored Vitamin D's effects on cellular processes relevant to cancer, such as cell growth, differentiation, and programmed cell death. They also examined clinical trials and observational studies investigating Vitamin D supplementation in cancer patients. The review found that Vitamin D, particularly its active form, appears to modulate several key pathways that could inhibit tumor growth and progression. Clinically, while some studies show promising results for Vitamin D supplementation as an additional therapy, especially for individuals with low Vitamin D levels, the findings are not consistent across all cancer types or treatment settings. The authors conclude that Vitamin D3 is a safe and potentially beneficial adjunct, but more rigorous, large-scale studies are needed to define optimal dosages and identify which patients would benefit most.

Dietary takeaway

While this review highlights the potential of Vitamin D3 in cancer care, it's important to remember that it's a supportive measure, not a standalone treatment. Ensuring adequate Vitamin D intake through sunlight exposure, fortified foods like milk and cereals, or fatty fish such as salmon and mackerel, is beneficial for overall health. However, any decisions about Vitamin D supplementation, especially for cancer prevention or treatment, should always be made in consultation with a healthcare professional, as research is still ongoing and one study alone cannot provide definitive answers.

Abstract

Vitamin D, also known as cholecalciferol, is a fat-soluble secosteroid that plays a critical role in regulating calcium and phosphate homeostasis and supporting bone health. Recent studies have highlighted its broad physiological and therapeutic applications, with particular focus on its anticancer properties. Vitamin D, through its active metabolite calcitriol, mediates a wide range of biological effects by modulating key cellular processes, including proliferation, differentiation, apoptosis, and angiogenesis. It is produced cutaneously after ultraviolet B exposure or obtained from dietary sources and then undergoes sequential hydroxylation in the liver and kidneys to form its biologically active compound. This review delineates the molecular underpinnings of vitamin D in cancer biology, emphasizing the interplay between genomic and non-genomic signaling pathways that collectively orchestrate tumor initiation and progression. Clinical evidence indicates that D supplementation shows promising therapeutic benefits as an adjunct to conventional cancer treatment, particularly in patients with vitamin D deficiency, although findings remain inconsistent across cancer types and clinical settings. Overall, current evidence supports vitamin D₃ as a safe, cost-effective, and promising adjuvant strategy in oncology; however, its routine clinical application requires validation through well-designed, large-scale randomized controlled trials to establish optimal dosing strategies, identify responsive patient populations, and confirm long-term efficacy and safety.

View on PubMed →DOI: 10.1007/s11033-026-12628-7